Showing results (11-20 of 147) with videos related to
Sort By:
Pageof 15
Nucleosides, Nucleotides & Nucleic Acids|October 27, 2005
A novel approach to solid phase chemical synthesis of oligonucleotide mRNA cap analogsJacek Jemielity, Petri Heinonen, Harri Lonnberg, et al.Future Medicinal Chemistry|June 26, 2013
Potential therapeutic applications of RNA cap analogsMarcin Ziemniak, Malwina Strenkowska, Joanna Kowalska, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|May 16, 2022
Chemically Modified Poly(A) Analogs Targeting PABP: Structure Activity Relationship and Translation Inhibitory PropertiesOlga Perzanowska, Miroslaw Smietanski, Jacek Jemielity, et al.Topics in Current Chemistry (Cham)|January 25, 2017
Applications of Phosphate Modification and Labeling to Study (m)RNA CapsMarcin Warminski, Pawel J Sikorski, Joanna Kowalska, et al.Nucleic Acids Research|June 10, 2020
5'-fluoro(di)phosphate-labeled oligonucleotides are versatile molecular probes for studying nucleic acid secondary structure and interactions by 19F NMRMarek R Baranowski, Marcin Warminski, Jacek Jemielity, et al.The Journal of Organic Chemistry|July 20, 2022
Quick Access to Nucleobase-Modified Phosphoramidites for the Synthesis of Oligoribonucleotides Containing Post-Transcriptional Modifications and Epitranscriptomic MarksKamil Ziemkiewicz, Marcin Warminski, Radoslaw Wojcik, et al.Organic Letters|September 13, 2012
Preparation of synthetically challenging nucleotides using cyanoethyl P-imidazolides and microwavesMalwina Strenkowska, Przemyslaw Wanat, Marcin Ziemniak, et al.Scientific Reports|August 23, 2017
Analysis of mononucleotides by tandem mass spectrometry: investigation of fragmentation pathways for phosphate- and ribose-modified nucleotide analoguesDominika Strzelecka, Sebastian Chmielinski, Sylwia Bednarek, et al.Nature Structural & Molecular Biology|November 5, 2016
Structural basis of mRNA-cap recognition by Dcp1-Dcp2Jeffrey S Mugridge, Marcin Ziemniak, Jacek Jemielity, et al.Accounts of Chemical Research|October 2, 2023
Chemical Modifications of mRNA Ends for Therapeutic ApplicationsMarcin Warminski, Adam Mamot, Anaïs Depaix, et al.Pageof 15